Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
17 November 2026 at 15:50
Isomorphic Labs, the AI drug-discovery platform that was spun out of Googleβs DeepMind in 2021, has raised $5 billion in a Series C funding round.